Your browser doesn't support javascript.
loading
Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1ß.
Agné, A; Richter, K; Padberg, W; Janciauskiene, S; Grau, V.
Afiliação
  • Agné A; Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, Justus-Liebig-University, Giessen, Germany.
  • Richter K; Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, Justus-Liebig-University, Giessen, Germany.
  • Padberg W; Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, Justus-Liebig-University, Giessen, Germany.
  • Janciauskiene S; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Member of the German Centre for Lung Research (DZL), Germany.
  • Grau V; Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, Justus-Liebig-University, Giessen, Germany; Member of the German Centre for Lung Research (DZL), Germany. Electronic address: Veronika.Grau@chiru.med.uni-giessen.de.
Pulm Pharmacol Ther ; 68: 102020, 2021 06.
Article em En | MEDLINE | ID: mdl-33774155

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa 1-Antitripsina / Deficiência de alfa 1-Antitripsina Limite: Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa 1-Antitripsina / Deficiência de alfa 1-Antitripsina Limite: Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha